2 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Sohail Rao: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB - Covid19 | Phase 2 | Unknown | Sohail Rao | 1000 | 2020-11-20 | 2022-03-29 |
| B2RAD Translational Medicine Study Specimen Collection - Specimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow Draw | Unknown | Sohail Rao | 1000 | 2020-01-22 | 2022-03-23 |
COVID-19 (1)
Specimen Handling (1) · bamlanivimab (1) · casirivimab (1) · imdevimab (1)
United States (2)